论文部分内容阅读
目的:观察糖化血红蛋白水平与急性脑卒中患者入院时神经功能的关系。方法:我们收集92例急性脑梗死病历,分为糖化血红蛋白升高组与正常组,入院24~48小时检测空腹血糖,糖化血红蛋白等指标,采用美国国立卫生研究院卒中量表(National Institutes of HealthStroke Scale,NIHSS)、改良Rankin量表(Modified Ranking Scale,mRs)、格拉斯哥昏迷量表(Glasgow Coma Scale,GCS)评分评价患者的神经功能,进行2组间评分的比较。结果:糖化血红蛋白升高组患者的NIHSS、mRs评分明显高于糖化血红蛋白正常组患者,而GCS评分要比糖化血红蛋白正常组低,2组间比较差异有统计学意义(p≤0.05)。结论:GHbA1c与卒中发生危险密切相关,通过控制GHbA1c水平有利于脑卒中的预防
Objective: To observe the relationship between the level of HbA1c and the neurological function of acute stroke patients on admission. Methods: We collected 92 cases of acute cerebral infarction, divided into glycated hemoglobin elevated group and normal group, admission 24 to 48 hours to detect fasting blood glucose, glycosylated hemoglobin and other indicators using the National Institutes of Health Stroke Scale (National Institutes of HealthStroke Scale, NIHSS), modified Rank Scale (mRs) and Glasgow Coma Scale (GCS) were used to evaluate the neurological function of patients. The scores of two groups were compared. Results: The scores of NIHSS and mRs in patients with elevated glycated hemoglobin were significantly higher than those in patients with normal glycated hemoglobin, while the GCS scores were lower than those in patients with normal glycosylated hemoglobin. There was significant difference between the two groups (p≤0.05). Conclusions: GHbA1c is closely related to the risk of stroke, which is beneficial to the prevention of stroke by controlling the level of GHbA1c